Jaguar Health (JAGX) Receivables - Net (2015 - 2026)
Jaguar Health (JAGX) posted quarterly Receivables - Net of $68000.0 for Q1 2026, down 94.44% year-over-year from $1.2 million in Q1 2025, and down 95.53% quarter-over-quarter from $1.5 million in Q4 2025.
Jaguar Health (JAGX) Receivables - Net (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Receivables - Net for 12 consecutive years, with $68000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables - Net fell 94.44% year-over-year to $68000.0; the TTM figure through Mar 2026 stood at $68000.0 (down 94.44% YoY), while the FY2025 annual figure was $1.5 million, changed 0.39% from the prior year.
- Receivables - Net retreated to $68000.0 in Q1 2026 per JAGX's latest filing, from $1.5 million in the prior quarter.
- Across five years, Receivables - Net topped out at $2.0 million in Q4 2023 and bottomed at $68000.0 in Q1 2026.
- Historically, Receivables - Net has averaged $1.4 million across 5 years, with a median of $1.5 million in 2024.
- Annual changes were most pronounced in 2024 — Receivables - Net surged 53.19% — and 2026, when it sank 94.44%.
- Jaguar Health's Receivables - Net stood at $1.9 million in 2022, then gained by 4.68% to $2.0 million in 2023, then slipped by 22.37% to $1.5 million in 2024, then retreated by 0.39% to $1.5 million in 2025, then slumped by 95.53% to $68000.0 in 2026.
- Business Quant data shows JAGX's Receivables - Net at $68000.0 in Q1 2026, $1.5 million in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.01 Bn | 132.16 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.79 Bn | 78.79 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn |
| 4 | Moderna | 60.18 Bn | 55.04 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.55 Bn | 28.24 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.19 Bn | 26.36 Bn | - |
| 10 | Jaguar Health | 457,710.26 | -9.61 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68,000.00 |
| Mar 31, 2026 | 68,000.00 |
| Dec 31, 2025 | 1.52 Mn |
| Dec 31, 2025 | 1.52 Mn |
| Sep 30, 2025 | 1.44 Mn |
| Sep 30, 2025 | 1.44 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | 1.22 Mn |
| Mar 31, 2025 | 1.22 Mn |
| Dec 31, 2024 | 1.53 Mn |
| Dec 31, 2024 | 1.53 Mn |
| Sep 30, 2024 | 1.25 Mn |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Dec 31, 2023 | 1.97 Mn |
| Dec 31, 2023 | 1.97 Mn |